KALA BIO, Inc. (LON:0JQ2)
London flag London · Delayed Price · Currency is GBP · Price in USD
0.3850
-0.0052 (-1.33%)
Feb 12, 2026, 3:16 PM GMT

KALA BIO Ratios and Metrics

Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
826155159278
Market Cap Growth
-82.46%77.94%-70.70%-13.71%-78.98%189.34%
Enterprise Value
1417-14246236
Last Close Price
0.285.645.489.5944.39275.03
PS Ratio
---15.647.0559.76
PB Ratio
-1.172.672.513.214.723.80
P/TBV Ratio
-2.672.513.214.723.80
EV/Sales Ratio
---13.105.5050.62
Debt / Equity Ratio
-3.462.624.842.264.771.01
Net Debt / Equity Ratio
-1.02-1.53-1.94-1.45-0.76-0.53
Net Debt / EBITDA Ratio
-0.210.470.380.340.120.56
Net Debt / FCF Ratio
-0.280.640.510.350.120.57
Asset Turnover
---0.030.060.03
Inventory Turnover
----0.590.54
Quick Ratio
0.653.026.102.792.957.38
Current Ratio
0.753.116.343.353.327.71
Return on Equity (ROE)
--388.29%-318.75%-250.56%-244.19%-160.89%
Return on Assets (ROA)
-65.81%-45.36%-34.28%-44.95%-37.89%-31.83%
Return on Capital Employed (ROCE)
551.30%-104.90%-82.20%-133.10%-107.30%-48.00%
Earnings Yield
-353.90%-116.81%-223.85%-73.65%-179.93%-27.44%
FCF Yield
-317.13%-89.75%-151.38%-130.17%-137.68%-24.37%
Buyback Yield / Dilution
-86.46%-56.09%-59.94%-15.50%-25.67%-53.11%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.